Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Arcadia Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get RKDA alerts

About Mark Kawakami

Mark Kawakami is recorded as CFO at Arcadia Biosciences, Inc. (RKDA) since July 5, 2024. Arcadia Biosciences, Inc. reported in an 8-K filed August 29, 2025 that Mark Kawakami resigned as principal accounting officer, effective September 12, 2025. Arcadia Biosciences, Inc. reported in an 8-K filed August 29, 2025 that Mark Kawakami resigned as chief financial officer, effective September 12, 2025. Arcadia Biosciences, Inc. reported in an 8-K filed July 8, 2024 that Mark Kawakami was appointed chief financial officer, effective July 5, 2024. The proxy statement of Arcadia Biosciences, Inc. reports total compensation of $218,425 for Mark Kawakami in fiscal 2025, including a base salary of $178,424. Disclosed compensation is on record for 3 fiscal years. Mark Kawakami has spoken on 3 earnings calls across 1 company, most recently for Arcadia Biosciences, Inc. on May 8, 2025. Arcadia Biosciences, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Arcadia Biosciences, Inc. includes Kevin Comcowich (CEO), Rajendra Ketkar (CEO), Stan Jacot (CEO) and 7 others.

“On August 26, 2025, Mark Kawakami, the chief financial officer and principal accounting officer of Arcadia Biosciences, Inc. (the “Company”), notified the Company that he was tendering his resignation as an officer and employee of the Company, effective September 12, 2025.”
Arcadia Biosciences, Inc. Form 8-K, filed August 29, 2025 · Read the filing
“On August 26, 2025, Mark Kawakami, the chief financial officer and principal accounting officer of Arcadia Biosciences, Inc. (the “Company”), notified the Company that he was tendering his resignation as an officer and employee of the Company, effective September 12, 2025.”
Arcadia Biosciences, Inc. Form 8-K, filed August 29, 2025 · Read the filing

Mark Kawakami on recent calls

“Joining me on the call today is T.J. Schaefer, Arcadia's President and Chief Executive Officer.”
CFO, Arcadia Biosciences, Inc. Q1 FY2025 Earnings Call ·
“Joining me on the call today is T.J. Schaefer, Arcadia's President and Chief Executive Officer.”
CFO, Arcadia Biosciences, Inc. Q4 FY2024 Earnings Call ·
“Joining me on the call today is T.J. Schaefer, Arcadia's President and Chief Executive Officer.”
CFO, Arcadia Biosciences, Inc. Q3 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at Arcadia Biosciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Arcadia Biosciences, Inc. (RKDA) $178,424 $218,425
2024 Arcadia Biosciences, Inc. (RKDA) $212,742 $370,175
2023 Arcadia Biosciences, Inc. (RKDA) — —

Recent activity